이상반응 보고
| VAERS ID | 2569881 |
|---|---|
| 성별 | 여성 |
| 나이 | 92세 |
| 주 코드 | IL |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | GH9694 |
| 예방접종 횟수 | 1 |
| 접종일 | 2022-11-29 |
| 발병일 | 2022-12-02 |
| 상태 | 입원 사망 |
증상
- 호흡곤란(Dyspnoea)
- 쌕쌕거림(Wheezing)
- 흉부 엑스레이 이상(Chest X-ray abnormal)
- 발성 장애(Dysphonia)
- 소변 분석(Urine analysis)
- 부종(Oedema)
- 생산적인 기침(Productive cough)
- 헤모글로빈 감소(Haemoglobin decreased)
- 빈혈증(Anaemia)
- 폐렴(Pneumonia)
- 호흡곤란(Respiratory distress)
- 죽음(Death)
- 전반적인 신체 건강 악화(General physical health deterioration)
이환 중 질병
only chronic issues.
지병
chronic pulmonary obstructive disease, HTN, chronic congestive heart failure, renal insufficiency
기타 의료
furosemide, iron sulfate, formoterol, montelukast, pantoprazole, budesonide, metoprolol, tramadol, calcium, enalapril
이전 예방접종
알레르기
codeine cyclobenzaprine
임상 검사
CXR: 12/08/2022 negative; Serum and UA labs: 12/22/2022 new onset anemia with hemoglobin 8.
2 with recent at baseline of 11.
4.
12/28/2022 CXR with multifocal pneumonia.
증상 상세
She received the Pfizer Bivalent inoculation on 11/29/2022, and at that time, was clinically stable with her acute issues with no recent exacerbations.
By 12/01/2022, she with productive cough, hoarseness, wheezing with shortness of breath.
this progressed over the next several days.
negative CXR, yet increasing respiratory distress/cough and edema.
she did not respond with any resolution of symptoms with steroids, diuretics, antibiotics.
she progressive worsening until sent to hospital on 12/28/2022 where had CXR with multifocal pneumonia and she expired on 12/29/2022.